In UC, duvakitug maintained high rates of clinical remission, clinical response, and endoscopic improvement at Week 44In CD, duvakitug maintained ...
Everyday Health on MSN
5 things you should be tracking when you have IBD
It can be helpful to keep tabs on symptoms, triggers, and other data to help manage inflammatory bowel disease. Find out what ...
Two experimental compounds derived from a phase II metabolite have demonstrated improved anti-inflammatory activity in ...
Dog diarrhea often stems from diet changes, stress or infection. Learn home care tips, dehydration signs and when symptoms ...
Oct 19 (Reuters) - Gilead Sciences said on Monday its experimental once-daily pill reduced symptoms of a chronic bowel ...
A new study shows that the 1,800-year-old Chinese formula Baitouweng Tang relieves ulcerative colitis by reshaping gut ...
Odyssey Therapeutics reports positive Phase 2a results for OD-001 in ulcerative colitis, indicating significant clinical efficacy and safety.
One-year results from SHINE-2 in children and adolescents with ulcerative colitis Of the patients enrolled in SHINE-2, 81% achieved clinical response at Week 12. Among responders, ages 6 to 17, ...
Omvoh-treated patients with ulcerative colitis achieved comprehensive disease control, a novel composite outcome defined by ...
A multi-cohort transcriptomic, genetic, and experimental study identifies the RHBDF2–ADAM17–TNFα axis as a molecular bridge ...
Odyssey Therapeutics ( ODTX) reported additional Phase 2a data supporting the clinical activity of OD-001, an oral treatment for ulcerative colitis, strengthening evidence for the drug's potential as ...
Takeda (TSE:4502/NYSE:TAK) announced new data from VERDICT (NCT04259138), showing that treating adults with intravenous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results